IJK
iShares S&P Mid-Cap 400 Growth ETF
SMB
Adj. R2
0.905
Rel. Sharpe
0.888
Mkt beta
0.91
AUM
US$10.1B
MER
0.17%
Valuation
130
ETF comparison
Verified factor-similar pair
IJK vs IVOG
These US-listed equity ETFs share verified FF6 US factor exposure. The modeled volatility of their factor-return difference is at or below 3% annualized on both the same 36-month window and a longer factor-history check.
SMB
Current similarity score
98
Very close factor fit
The score is 100 for identical fitted exposures and 80 at the 3% modeled tracking-error limit. It includes market and non-market factors; it does not indicate which fund earned or is expected to earn more. How to read this score.
Quick Read
- IVOG has the higher backtested relative Sharpe (0.906 vs 0.888).
- IVOG has the lower published fee (0.10% vs 0.17%).
- IJK is cheaper on dividend valuation (130 vs 143, where 100 is each fund's historical median).
- IVOG has the stronger regression fit (adjusted R-squared 0.912 vs 0.905).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
IVOG
Vanguard S&P Mid-Cap 400 Growth ETF
SMB
UMD
Adj. R2
0.912
Rel. Sharpe
0.906
Mkt beta
0.91
AUM
US$1.5B
MER
0.10%
Valuation
143
Market beta uses the common 36-month window through 2026-08. Adjusted R² and relative Sharpe describe each fund's separately published full-history model.
Factor Exposure Match
Blue bars compare factor beta magnitude from the same 36 months shown above. Green bars compare absolute t-stat strength; dim bars indicate |t| below 1.96. Every factor enters the distance calculation regardless of its t-statistic.
SMB
diff -0.02
HML
diff +0.02
RMW
diff -0.01
CMA
diff +0.00
UMD
diff -0.01
What Happened Over the Same 36 Months
IJK adjusted total-return CAGR
14.99%
IVOG adjusted total-return CAGR
15.04%
IVOG ahead by 0.06 percentage points/year over 2023-09 through 2026-08. This is the observed difference between annualized compounded returns from adjusted prices, not an expected return or a factor-model estimate.
Historical factor attribution
Signed contribution to IJK minus IVOG, percentage points/year, using fitted 36-month exposures and average factor returns over those same months:
Market factor
+0.04
Other factors, combined
+0.12
Total factor-implied difference
+0.17
This arithmetic-average factor attribution excludes the regression intercept and fund-specific return. It therefore need not equal the observed CAGR difference and is not a forecast.
Why This Pair Matches
Modeled factor tracking error · 36m
0.24%/yr
Modeled tracking error · 120m factor history
0.30%/yr
Mkt beta diff
0.00
Rel. Sharpe diff
0.018
Fitted exposures and factor covariance estimate the volatility, not the average or direction, of the funds' modeled return difference. The common regression window is 2023-09 through 2026-08. A short-window estimate and a longer factor-history check must both be at or below 3.000%; this is a screening limit, not a forecast. Holdings, turnover, taxes and trading costs require a separate review. The Sharpe figures elsewhere on this page come from each fund's published full-history model and do not enter similarity ranking. See the full methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.